Abstract
Biomarkers are indicators of a biological state and have a pivotal role in estimations of disease risk, early detection, assessment of progression and outcomes prediction. Studies of cancer biomarkers are published daily, some are well characterized, while others are of growing interest. Managing this flow of information is challenging for scientists and clinicians. We sought to validate an AI-driven literature interrogation method and a publicly available tool to help researchers identify these emergent biomarkers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
